Last week, amid a flurry of election policies and debates, a striking report found that cancer survival in England currently lags up to 25 years behind European countries like Sweden, Norway and Denmark. From bowel cancer to breast diagnoses, England is firmly lagging behind our Scandinavian neighbours. What’s to blame?
Why aren’t major parties discussing how this decline could be reversed in their manifestos?
The revelation by Macmillan Cancer Support is the legacy of many years of underfunding, resulting in delays to diagnosis and treatment.
Already a subscriber? Log in
Black Friday sale
Subscribe today and get 10 weeks of The Spectator Australia for just $1
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Black Friday sale
Subscribe today and get 10 weeks of The Spectator Australia for just $1
SUBSCRIBEAlready a subscriber? Log in